Assembly Biosciences, Inc. (ASMB) vs Prothena Corporation plc (PRTA)

A side-by-side comparison of Assembly Biosciences, Inc. and Prothena Corporation plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ASMB vs PRTA

growth of $100 · dividends reinvested · last 10y
ASMB -76.4% (-13.4%/yr)PRTA -86.6% (-18.2%/yr)ASMB compounded faster over this window
0200400600800Start $10020182020202220242026$24$13
ASMB PRTA

ASMB vs PRTA: by the numbers

  • •ASMB is the larger company ($440M vs $420M market cap).
  • •Both run net losses; ASMB's is the smaller (-0.06% vs -80.67% net margin).
  • •PRTA grew revenue faster over the past five years (62.57% vs -1.78% CAGR).

Metrics side by side

Valuation

MetricASMBPRTA
P/E ratio40.33N/A
Forward P/EN/A72.91
P/S ratio5.877.70
P/B ratio1.441.46

Profitability

MetricASMBPRTA
Gross margin99.82%61.77%
Operating margin-11.75%-1905.82%
Net margin-0.06%-80.67%
ROE-0.01%-15.33%
ROIC-2.86%-21.36%

Growth (annualized)

MetricASMBPRTA
Revenue CAGR (5Y)-1.78%62.57%
Total return CAGR (5Y)-10.66%-35.08%

Frequently asked

Which has grown faster, ASMB or PRTA?
Over the past five years, PRTA grew revenue faster — ASMB at a -1.78% CAGR versus PRTA at 62.57%.
How have ASMB and PRTA total returns compared?
Over the past 10 years, ASMB delivered -13.41% and PRTA delivered -18.37% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.